Voya Investment Management LLC Provention Bio, Inc. Transaction History

Voya Investment Management LLC

  • $85.7 Billion
  • Q2 2024

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022
BUY
$3.43 - $5.62 $8,362 - $13,701
2,438 Added 11.04%
24,520 $110,000
Q4 2021

Feb 14, 2022
SELL
$5.59 - $7.39 $799 - $1,056
-143 Reduced 0.64%
22,082 $124,000
Q1 2021

May 17, 2021
BUY
$10.12 - $19.45 $15,119 - $29,058
1,494 Added 7.21%
22,225 $233,000
Q4 2020

Feb 16, 2021
BUY
$11.79 - $18.94 $62,758 - $100,817
5,323 Added 34.55%
20,731 $351,000
Q3 2020

Nov 16, 2020
BUY
$10.34 - $15.2 $8,468 - $12,448
819 Added 5.61%
15,408 $198,000
Q2 2020

Aug 14, 2020
BUY
$7.81 - $17.0 $113,940 - $248,013
14,589 New
14,589 $206,000

Others Institutions Holding PRVB

# of Institutions
1
Shares Held
170K
Call Options Held
0
Put Options Held
0
View Full List

About Provention Bio, Inc.

PRVB Quotes by TradingView
  • Ticker PRVB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 81,549,904
  • Description
  • Provention Bio, Inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of therapeutics and solutions to intercept and prevent immune-mediated diseases. Its products candidates include PRV-031 teplizumab and monoclonal antibodies (mAb) that is in Phase III clinical trial for the interception of type one...
More about PRVB
Track This Portfolio

Track Voya Investment Management LLC Portfolio

Follow Voya Investment Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Voya Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Voya Investment Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email